Prevail Therapeutics raises $50M for gene therapy in Parkinson’s, other neurodegenerative disorders
The company hopes the funding will move it toward the clinic. Active clinical programs of gene therapies in Parkinson's include efforts by Voyager Therapeutics and a university in Japan.
